Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 02, 2015 7:04 AM ET


Company Overview of Onconova Therapeutics, Inc.

Key Executives for Onconova Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Ramesh Kumar Ph.D.13 RelationshipsCo-Founder, Chief Executive Officer, President and Director59
E. Premkumar Reddy Ph.D.13 RelationshipsFounder, Lead Scientific Advisor and Director71
Ajay Bansal No RelationshipsChief Financial Officer and Secretary53
Thomas J. McKearn M.D., Ph.D.22 RelationshipsPresident of Research and Development66
Steven M. Fruchtman M.D.No RelationshipsChief Medical Officer and Senior Vice President of Research & Development64
View More Key Executives

Onconova Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Michael B. Hoffman J.D. 92 RelationshipsRiverstone Holdings LLC65
Ramesh Kumar Ph.D. 13 RelationshipsOnconova Therapeutics, Inc.59
E. Premkumar Reddy Ph.D. 13 RelationshipsOnconova Therapeutics, Inc.71
Viren Mehta Pharma.D. 13 RelationshipsMehta Partners LLC65
Anne M. VanLent 62 RelationshipsOcera Therapeutics, Inc.67
View All Board Members

Onconova Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Anne M. VanLent62 Relationships3 Executives
Compensation Committee J.D.Michael B. Hoffman92 Relationships3 Executives
Nominating Committee Pharma.D.Viren Mehta13 Relationships3 Executives
Corporate Governance Committee Pharma.D.Viren Mehta13 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$713.4K
Compensation as of Fiscal Year 2014
Onconova Therapeutics, Inc. CEO Compensation
Industry Average


Colgate-Palmolive Co. Appoints Mukul Deoras as Global Chief Marketing Officer
July 02, 2015 6:50 AM ET
Vinda International Holdings Limited Announces Board Changes
June 30, 2015 8:30 AM ET
Pee Cee Cosma Sope Ltd Announces Executive Changes
June 23, 2015 9:49 AM ET
Kimberly-Clark Elects Michael D. White to its Board of Directors
June 22, 2015 1:00 PM ET
Hipolin Announces Resignation of Nilesh Rajnikant Desai as Independent Director
June 10, 2015 10:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Onconova Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at